☆ 4.6 Article

Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design

JOURNAL OF CLINICAL VIROLOGY (2022)

Related references

Note: Only part of the references are listed.

Review Virology

The variability of the serological response to SARS-corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity)

Georg Bauer

Summary: Analysis of 16 recent reports on the serological response to SARS-CoV-2 showed high variability, with IgM and IgG responses unable to clearly distinguish early, intermediate, and past infections. A proposed model explains this variability and suggests the potential use of avidity determination for various diagnostic and epidemiological applications, including COVID-19 diagnosis and vaccination program control.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Virology

Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies

Maria Infantino et al.

Summary: Including IgA antibody determination in serological tests of COVID-19 diagnosis can improve diagnostic accuracy. IgA antibodies play a crucial role in bridging the serological gap of COVID-19, with their concentrations potentially being more than twice as high as IgG. Variations among anti-SARS-CoV-2 IgG assays should be taken into consideration when interpreting results.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Infectious Diseases

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study

Wan Ni Chia et al.

Summary: The study investigated the dynamics of neutralising antibody response in patients who have recovered from COVID-19, finding great variations and suggesting that predicting immune longevity can only be accurately determined at the individual level. The findings emphasize the importance of public health and social measures in the ongoing pandemic outbreak response, and may have implications for the longevity of immunity after vaccination.

LANCET MICROBE (2021)

Add to Collection

Review Medicine, General & Internal

The Proportion of SARS-CoV-2 Infections That Are Asymptomatic A Systematic Review

Daniel P. Oran et al.

Summary: Available data suggests that at least one third of SARS-CoV-2 infections are asymptomatic. Longitudinal studies indicate that nearly three quarters of individuals who test positive via PCR but show no symptoms at the time of testing will remain asymptomatic. Control strategies for COVID-19 need to be adjusted considering the prevalence and transmission risk of asymptomatic SARS-CoV-2 infections.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Article Cell Biology

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin et al.

Summary: The study found that humoral immune responses to SARS-CoV-2 infection are dominated by IgA antibodies, with specific IgA plasmablasts rapidly expanding shortly after symptom onset and peaking in the third week of the disease. Virus-specific antibody responses include IgG, IgM, and IgA, with IgA playing a greater role in virus neutralization compared to IgG.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Medical Laboratory Technology

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories

Y. Victoria Zhang et al.

Summary: This document aims to provide a comprehensive reference for laboratory professionals and healthcare workers to appropriately implement SARS-CoV-2 serologic assays in the clinical laboratory and to interpret test results during this pandemic. It discusses the verification and validation of EUA and LDT assays, along with a quality management approach. Recommendations for serologic testing indications, result interpretation and the role of orthogonal testing are presented.

CLINICAL CHEMISTRY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

Matthew K. Siggins et al.

Summary: Respiratory viruses contribute significantly to the global burden of disease, and understanding the role of immunity in protection and resolution of diseases caused by these viruses, particularly in the face of challenges like COVID-19, is crucial.

TRENDS IN MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

Jackson S. Turner et al.

Summary: The study found that individuals who had recovered from mild SARS-CoV-2 infections showed rapid decline of serum anti-SARS-CoV-2 spike protein antibodies in the first 4 months after infection, followed by a more gradual decrease over the following 7 months but remaining detectable at least 11 months after infection. This suggests that mild infection with SARS-CoV-2 can induce robust antigen-specific, long-lived humoral immune memory in humans.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Michael J. Peluso et al.

Summary: Interpretation of SARS-CoV-2 serosurveillance studies is constrained by varied performance of antibody assays based on disease severity, timing, and type of assay used. Antibody responses were consistently lower in individuals with mild infection, with sensitivity of commercial assays ranging widely. These findings highlight the importance of considering these factors in the design and interpretation of serosurveillance studies.

SCIENCE ADVANCES (2021)

Add to Collection

Article Immunology

Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Lisa Henss et al.

Summary: The study found that the severity of COVID-19 is correlated with patient age, gender, the amount of SARS-CoV-2-specific antibodies, and their neutralization activity. The levels of specific antibodies decrease over time, with faster decline in nucleoprotein antibodies. NL63 neutralizing activities are associated with COVID-19 severity, suggesting potential cross-reactive protection.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study

Shufa Zheng et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Multidisciplinary Sciences

Virological assessment of hospitalized patients with COVID-2019

Roman Woelfel et al.

NATURE (2020)

Add to Collection

Article Immunology

Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Ger Rijkers et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction

Chee Wah Tan et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Editorial Material Medicine, General & Internal

COVID-19 and the Path to Immunity

David S. Stephens et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Jeffrey D. Whitman et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Review Multidisciplinary Sciences

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Angkana T. Huang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Immunology

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

Hejun Liu et al.

IMMUNITY (2020)

Add to Collection

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Xiangyu Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Immunology

Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site

V Manivel et al.

IMMUNITY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.